Seller representation
Sale of a company or business line, for founders, families and PE shareholders.
- Strategic repositioning ahead of a sale
- Information memorandum and blind profile
- Buyer identification, pricing and negotiation through to closing
Affinity with Finance · Principal advisory · Belgium
Afinicon advises companies, shareholders, family offices and institutional investors on strategic review, M&A, capital raising and fund structuring. One principal leads every mandate from first analysis to close.
Discuss a mandate →Advisory
Mandates cover the full capital lifecycle, from investment strategy to exit. Each is run by a principal with portfolio management and transaction experience, not handed down to a junior team.
Sale of a company or business line, for founders, families and PE shareholders.
Acquisitions and buy-and-build programmes, from target search to closing.
Venture, growth and debt financing, including syndicate construction and investor engagement.
Setting strategic direction and targets, the organisation to deliver them, and the process to keep them on track.
Fast, decisive support for companies that underperform or face a liquidity crisis, and for their lenders and investors.
Senior finance capacity for SMEs, from a single assignment to a long-term commitment, without the fixed cost of a full-time CFO.
Set-up, governance and reorganisation of family offices and private investment vehicles.
Concept, legal and governance structure, service providers and fundraising for new investment funds.
Track record
A selection of mandates from close to fifteen years of advisory work, since 2011.
Divestiture of a contract services business. Details to be announced.
Sell-side adviserBelgian pharmaceutical consultancy in pharmacovigilance, quality management, medical information and market access. Strategic review and full exit process, leading to the merger with PharmaLex Group in 2021. PharmaLex was later acquired by AmerisourceBergen, now Cencora.
PharmaLex announcement ↗ Strategic & financial adviserFund-of-funds that co-invests with BIO, the Belgian development finance institution, in private equity funds in Africa and Asia. Structured and launched from inception with Belgian institutional investors.
SDG Frontier Fund at BIO ↗ Fund management company directorSet-up and coordination of an RFP system and fund manager selection, Brussels and London.
Website ↗ Investment consultantFounder
Thirty years in institutional asset management, private equity and impact finance, across Brussels, Paris, Boston and The Hague.
Head of Healthcare Investments and Research at ING Investment Management (USD 1.5bn). Head of Sector Funds in the Generale Bank, Fimagen and Fortis network, where he launched a global biotech fund. Portfolio manager and member of the Strategic Asset Allocation Committee at Argenta Asset Management, where he designed and launched the Argenta Portfolio Select fund range in November 2025.
Founded Afinicon in 2011 to combine investment strategy with transaction execution.
The group
Afinicon is the operating advisory firm. Two further activities are being built on the proprietary macro-quantitative framework the founder has developed since 1994, challenging the current paradigm of asset management.
M&A, strategic review, funding, restructuring, virtual CFO and family office services for companies, shareholders and investors.
A rules-based multi-asset investment approach built on a proprietary regime framework. Aginios is in formation and does not yet offer any product or service.
Software for insurers, pension funds and regulated asset managers: consolidated portfolio view, regime-based exposure assessment and mandate alignment.
Nothing on this website is an offer or solicitation to buy or sell any financial instrument or fund unit, or investment advice. Aginios and FSG are under development and are not authorised or registered with any supervisory authority at this stage.
Contact
For a sale process, a strategic review, a financing round or a family office question, write directly. First conversations are confidential and without commitment.